EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-89
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

In this study, the investigators hypothesize that observed intense resistance training with conditioning elicits similar changes in body composition, muscle mass, and blood pressure as that with cardiovascular training (or cardio) for women treated with breast cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 20-89 years

Women prescribed exercise as a SOC

Women with a biopsy proven diagnosis of ductal carcinoma in situ (DCIS) or invasive carcinoma of the breast

Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.

Disqualifiers

Any current treatment with cytotoxic chemotherapy for breast cancer

Inability to safely engage in group sessions of resistance training as deemed by study PI

Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

Beta blocker or GLP-1 inhibitor medications

Trial design

Design model

Parallel

Treatments tested in this trial

  • Resistance Training with Cardio

    Behavioral

    Participants in this arm will engage in a supervised exercise regimen three times per week, for approximately 2 months (8 weeks). The regimen combines two days of hypertrophy-focused resistance training with a third day dedicated to steady-state cardiovascular exercise. The cardio day will utilize ergometer-based exercises (rowing ergometer, Assault Air Bike) and unweighted sled pushes, with each activity lasting 10 minutes continuously. The overall program aims to improve cardiorespiratory fitness and body composition in breast cancer survivors, under the guidance of Certified Strength and Conditioning Specialists (CSCS).

  • Resistance Training with Conditioning

    Behavioral

    Participants in this arm will engage in a supervised exercise regimen three times per week, for approximately 2 months (8 weeks). The regimen combines two days of hypertrophy-focused resistance training with a third day dedicated to high-intensity conditioning. The conditioning day involves a circuit format of 6 total exercises, completed for 8 repetitions each across 8 sets, with limited rest periods (10 seconds or less) between exercises and sets. Exercise selection is total-body focused, alternating between upper and lower body movements. The program aims to improve muscular conditioning and body composition in breast cancer survivors, under the guidance of Certified Strength and Conditioning Specialists (CSCS).

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Cardio TrainingExperimental treatment 1 intervention
Group B: Conditioning TrainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Muscle Mass

Measured as total muscle mass (kg), determined via InBody 970 bioimpedance analysis and ultrasound (BodyMetrix) for muscle tissue thickness.

Time frame
Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).
2

Change in Fat Mass

Measured as total fat mass (kg), determined via InBody 970 bioimpedance analysis and ultrasound (BodyMetrix) for adipose tissue thickness.

Time frame
Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).

Secondary outcomes

1

Change in Blood Pressure

Pre-workout blood pressure (systolic and diastolic) measurements.

Time frame
Baseline (Prior to Program), at Month 1, and At Exercise Program Completion (approximately 2 months).
2

Change in Resting Metabolic Rate

Resting metabolic rate (RMR) at the completion of the exercise regimen.

Time frame
At Exercise Program Completion (approximately 2 months).
3

Change in Body Composition Metrics (Other than Muscle/Fat Mass)

Includes body mass, % fat, and % fat-free mass, measured via InBody 970 bioimpedance analysis.

Time frame
Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).
4

Change in Phase Angle

Phase angle, determined via InBody 970 bioimpedance analysis.

Time frame
Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.